News

FDA recommends changing blood donor policy for MSM


 

Blood for transfusion

Photo by Elisa Amendola

The US Food and Drug Administration (FDA) is recommending a change to the policy that prevents men who have sex with men (MSM) from donating blood, according to FDA Commissioner Margaret A. Hamburg.

The FDA would like to allow MSM to donate blood if they have abstained from sexual contact for 1 year.

The agency intends to issue a draft guidance recommending this policy change in 2015. The guidance will be open for public comment.

In a prepared statement, Hamburg said that, over the past few years, the FDA and other government agencies have carefully considered the scientific evidence relevant to the blood donor deferral policy for MSM.

This review, as well as the recommendations of advisory committees to the US Department of Health and Human Services (HHS) and the FDA, has prompted the FDA to recommend the change.

“This recommended change is consistent with the recommendation of an independent expert advisory panel, the HHS Advisory Committee on Blood and Tissue Safety and Availability, and will better align the deferral period with that of other men and women at increased risk for HIV infection,” Hamburg said.

“Additionally, in collaboration with the NIH’s National Heart Lung and Blood Institute (NHLBI), the FDA has already taken steps to implement a national blood surveillance system that will help the agency monitor the effect of a policy change and further help to ensure the continued safety of the blood supply.”

Recommended Reading

Studies show TRALI underreported, TACO on the decline
MDedge Hematology and Oncology
FDA approves pathogen inactivation system for platelets
MDedge Hematology and Oncology
Amount of blood transfused doesn’t affect long-term mortality
MDedge Hematology and Oncology
FDA approves pathogen inactivation system for plasma
MDedge Hematology and Oncology
FDA approves first supplemental test for HTLV-I/II
MDedge Hematology and Oncology
FDA OKs use of system to treat Ebola convalescent plasma
MDedge Hematology and Oncology
Device could streamline preparation of frozen RBCs
MDedge Hematology and Oncology
Will US lift ban on MSM blood donation?
MDedge Hematology and Oncology
Strategy could reduce TRALI after platelet transfusion
MDedge Hematology and Oncology
ASH adds practices to Choosing Wisely list
MDedge Hematology and Oncology